RxDoctor Payments Data

Kimberly Sherrill, MD

Psychiatry · Little Rock, ARNPI 1689668089

Payments from drug & device makers

$655in general payments, 2019–2025

Across 37 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$131
  • Sunovion Pharmaceuticals Inc.$131
  • Johnson & Johnson$126
  • Lundbeck LLC$49
  • Alkermes, Inc.$43
  • Takeda Pharmaceuticals U.S.A., Inc.$34
  • plus $141 from 7 others

What the payments were for

  • Food & beverage$655100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$655 in reported general payments places this provider in the 60th percentile of 235 psychiatry providers in Arkansas.

See all psychiatry providers in Arkansas

Medicare billing

Part B allowed, 2024
$10,536
Medicare patients
19
Services billed
163

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl26$35,894
Duloxetine Hcl51$1,105
Venlafaxine Hcl ErVenlafaxine Hcl66$1,064
Quetiapine Fumarate76$964
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine23$626
Bupropion XlBupropion Hcl33$522
Aripiprazole15$502
Alprazolam60$460
Amitriptyline Hcl13$454
Divalproex Sodium27$401
Lamotrigine45$306
Mirtazapine25$302
Bupropion Hcl SrBupropion Hcl30$238
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$228
Nortriptyline Hcl15$194

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$17$35,89426 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 235 psychiatry providers in Arkansas.

Other psychiatry in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →